antifungal resistance – Page 8

Evaluation of the Cytotoxicity and Antifungal Efficacy of Crocus sativus (saffron) Petals on Clinical Isolates of Candida albicans

mycolabadmin

Researchers tested saffron petals as a natural antifungal treatment against Candida albicans, a common fungal infection. While the saffron extract was less potent than the standard drug fluconazole, it showed promise as a safer alternative with minimal toxicity to human cells. The findings suggest saffron petals could be a cost-effective herbal option for treating fungal infections, especially as resistance to conventional antifungals increases.

Fungal Keratitis Caused by Humicola sardiniae

mycolabadmin

A 78-year-old man developed a serious fungal eye infection caused by Humicola sardiniae, a fungus rarely seen in humans. The infection was difficult to treat because the fungus was resistant to most antifungal medications, and continued use of steroid eye drops worsened the condition. After switching to appropriate antifungal treatment and stopping the steroids, the patient’s cornea eventually healed over four months, though this was the first documented case of this particular fungus infecting a human.

Detection of Multiple Nosocomial Trichosporon asahii Transmission Events via Microsatellite Typing Assay, South America

mycolabadmin

Researchers developed a new genetic fingerprinting test to track and identify outbreaks of a dangerous fungal infection called Trichosporon asahii in hospitals across South America. The test uses microsatellite markers to create a detailed genetic profile of different fungal isolates, making it much better at detecting when infections spread from patient to patient compared to older methods. This discovery revealed multiple hidden disease clusters in hospitals, including one that occurred over 13 years, highlighting the importance of this new surveillance tool for hospital infection control.

Antifungal stewardship in the UK: where are we now?

mycolabadmin

Fungal infections are becoming more common and dangerous because some fungi are developing resistance to antifungal medicines. UK hospitals struggle to manage these infections due to lack of funding, staffing, and limited access to fungal testing services. The paper recommends creating regional fungal expertise centers and setting national standards to improve how antifungal medications are used and monitored across the country.

Loss of the Aspergillus fumigatus spindle assembly checkpoint components, SldA or SldB, generates triazole heteroresistant conidial populations

mycolabadmin

This research reveals that disabling certain cell division checkpoint proteins in the fungus Aspergillus fumigatus creates populations resistant to triazole antifungal drugs. The resistant fungal cells appear to have abnormal amounts of genetic material, suggesting that loss of these checkpoint controls allows cells with extra chromosomes to survive drug exposure. This discovery provides new insight into how dangerous fungal infections can develop resistance to our most important antifungal treatments.

Multi-omics Analysis of Experimentally Evolved Candida auris Isolates Reveals Modulation of Sterols, Sphingolipids, and Oxidative Stress in Acquired Amphotericin B Resistance

mycolabadmin

Researchers studied how the fungus Candida auris develops resistance to amphotericin B, an important antifungal drug. By evolving two laboratory strains of this fungus under drug pressure, they discovered two different ways the fungus can become resistant: one through stress management genes, the other through changes in its protective lipids. These findings help explain why some clinical infections with this dangerous fungus are so hard to treat.

Ploidy plasticity drives fungal resistance to azoles used in agriculture and clinics

mycolabadmin

Researchers discovered that a common agricultural fungicide can cause fungal cells to change their genetic structure in ways that make them resistant to medicines used to treat human infections. The fungus Candida tropicalis can switch to a haploid state (single copy of genes instead of two) when exposed to this agricultural chemical, and these altered cells become resistant to both agricultural and medical antifungal drugs. This explains how resistance that develops in agricultural settings can spread to clinical settings, creating a public health threat.

Prevalence and antifungal susceptibility profiles of Candida isolates among patients with candiduria: a multiplex PCR assay

mycolabadmin

Researchers studied fungal infections in urine samples from hospitalized patients and found that while the common yeast Candida albicans was most prevalent, other Candida species were increasingly resistant to antifungal medications. Using advanced genetic testing methods, they identified seven different Candida species and tested their resistance to three common antifungal drugs. The findings highlight the growing problem of drug-resistant fungal infections and the need for better diagnostic tools to identify which species is causing infection so appropriate treatment can be selected.

Evaluation of Clinical, Microbiological Profiles and Management Patterns with Outcomes of Patients with Fungal Isolates in An Intensive Care Unit of A Tertiary Care Center: A Prospective Observational Study

mycolabadmin

This study examined fungal infections in intensive care unit patients at a major hospital in India. Researchers found that diabetes was the most common risk factor, and most infections were caused by Candida species found in urine samples. Many fungal isolates were resistant to common antifungal drugs like fluconazole, suggesting doctors need to be more careful about which medications they use to treat these infections.

Aspergillus fumigatus ctf1 – a novel zinc finger transcription factor involved in azole resistance

mycolabadmin

Researchers discovered that a gene called ctf1 in a harmful fungus called Aspergillus fumigatus helps control how resistant the fungus is to antifungal medications like voriconazole. When this gene is removed, the fungus becomes more resistant to these drugs because it pumps them out more efficiently. Understanding this mechanism could help doctors develop better treatments for serious fungal infections in vulnerable patients.

Research Topic: antifungal resistance